The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID ‐19 pandemic-Reference-Cited by-同舟云学术

The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID ‐19 pandemic

Published:2020-06-05 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Shah Monica¹^ORCID,Sachdeva Muskaan¹,Dodiuk‐Gad Roni P.²³⁴

Affiliation:

1. Faculty of Medicine University of Toronto Toronto Ontario Canada

2. Division of Dermatology, Department of Medicine Sunnybrook Health Sciences Centre Toronto Ontario Canada

3. Department of Dermatology Ha'emek Medical Center Afula Israel

4. Ruth and Bruce Rappaport Faculty of Medicine Technion Institute of Technology Haifa Israel

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13524

Reference9 articles.

1. Coronavirus disease 2019 (COVID‐19). U.S. Food and Drug Administration.https://www.fda.gov/emergency‐preparedness‐and‐response/counterterrorism‐and‐emerging‐threats/coronavirus‐disease‐2019‐covid‐19#new.2020. Accessed April 13 2020.

2. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic

3. FarrC.Patients with autoimmune diseases are running out of hydroxychloroquine. CNBC.https://www.cnbc.com/2020/04/07/patients-with-autoimmune-diseases-running-out-of-hydroxychloroquine.html.2020. Accessed April 13 2020.

4. Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric drug development issues during public health emergencies;Essentials of Translational Pediatric Drug Development;2024

2. [Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19;Actas Dermo-Sifiliográficas;2022-02

3. Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19;Actas Dermo-Sifiliográficas (English Edition);2021-11

4. La hidroxicloroquina como fármaco fundamental en dermatología y su papel controvertido en la COVID-19;Actas Dermo-Sifiliográficas;2021-08

5. The impact of the global COVID‐19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis;British Journal of Clinical Pharmacology;2020-07-26